Document Detail

Values of troponin T and myoglobin predictive of non-cardiac ischemia in rats.
Jump to Full Text
MedLine Citation:
PMID:  24967059     Owner:  NLM     Status:  PubMed-not-MEDLINE    
OBJECTIVES: Biochemical markers are important for the timely diagnosis and follow-up of ischemic events. Most of the markers have been previously studied in the context of cardiac ischemia. However, research on markers of non-cardiac events has been insufficient. Therefore, we investigated the relationship between troponin and myoglobin which are commonly used markers of cardiac ischemia, in non-cardiac ischemia.
MATERIALS AND METHODS: Forty-eight rats were equally divided into six groups. Group I was the control group. Group II was the sham group and received a simple laparotomy. The superior mesenteric artery was clamped in groups III and IV in order to create mesenteric ischemia. The left femoral artery was clamped in groups V and VI in order to create peripheral ischemia. Intracardiac blood samples were taken from all groups (during the 3(rd) hour of ischemia in groups III and V and the 6(th) hour of ischemia in group IV and VI) and troponin T and myoglobin levels were measured.
RESULTS: Troponin and myoglobin levels were statistically similar in groups I and II. Moreover, increments were detected for troponin and myoglobin in ischemia groups according to group I and II. Furthermore, higher troponin Tlevels were detected after three hours of mesenteric ischemia and higher myoglobin values were observed after six hours of mesenteric ischemia (P<0.05).
CONCLUSION: Troponin T and myoglobin are not specific for non-cardiac ischemia, and they may be useful for detecting other ischemic events.
Orkut Guclu; Ahmet Caliskan; Oguz Karahan; Sinan Demirtas; Suleyman Yazici; Celal Yavuz; Binali Mavitas
Related Documents :
23694919 - Adenosine stress thallium-201 myocardial perfusion imaging for detecting coronary arter...
25128749 - Impaired coronary microvascular and left ventricular diastolic function in patients wit...
23550029 - Microsphere embolisation as an alternative for alcohol in percutaneous transluminal sep...
17342959 - Electrocardiography: the ecg.
16640509 - Decision support for the initial triage of patients with acute coronary syndromes.
23773639 - The effects of undifferentiated spondyloarthropathy on left ventricular systolic and di...
25461169 - Graphene oxide-based biosensor for detection of platelet-derived microparticles: a pote...
22666259 - The association between myocardial iron load and ventricular repolarization parameters ...
6113759 - Improved right ventricular function and reduced pulmonary vascular resistance during pr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Iranian journal of basic medical sciences     Volume:  17     ISSN:  2008-3866     ISO Abbreviation:  Iran J Basic Med Sci     Publication Date:  2014 May 
Date Detail:
Created Date:  2014-06-26     Completed Date:  2014-06-26     Revised Date:  2014-06-30    
Medline Journal Info:
Nlm Unique ID:  101517966     Medline TA:  Iran J Basic Med Sci     Country:  Iran    
Other Details:
Languages:  eng     Pagination:  318-21     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Iran J Basic Med Sci
Journal ID (iso-abbrev): Iran J Basic Med Sci
Journal ID (publisher-id): IJBMS
ISSN: 2008-3866
ISSN: 2008-3874
Publisher: Mashhad University of Medical Sciences, Iran
Article Information
Download PDF
Copyright: © Journal Management System. Created by sinaweb
Received Day: 03 Month: 9 Year: 2013
Accepted Day: 28 Month: 1 Year: 2014
Print publication date: Month: 5 Year: 2014
Volume: 17 Issue: 5
First Page: 318 Last Page: 321
PubMed Id: 24967059
ID: 4069840
Publisher Id: IJBMS-17-318

Values of troponin T and myoglobin predictive of non-cardiac ischemia in rats
Orkut Guclu1*
Ahmet Caliskan1
Oguz Karahan1
Sinan Demirtas1
Suleyman Yazici1
Celal Yavuz1
Binali Mavitas1
1Medical School of Dicle University, Department of Cardiovascular Surgery, Diyarbakir, Turkey
*Corresponding author: Orkut Guclu. Department of Cardiovascular Surgery, Medical School of Dicle University, Diyarbakir/Turkey. Tel: 00904122488000; Fax: 00904122488001; email:


Ischemia is defined as inadequate delivery of oxygen to cells of different parts of the body, such as the intestines and limbs. It can be acute, chronic or acute superimposed on chronic (1). Biochemical markers may be released during the ischemic period. These markers (e.g. creatinine kinase, myoglobin and troponins) have been used to diagnose cardiac ischemia in clinical practice (2). Previous studies have shown that troponin T and myoglobin have excellent sensitivity for the diagnosis of acute myocardial infarction, but currently no available plasma biomarker has been proven to be enough specific to serve as an early diagnostic test for non-cardiac ischemia (2, 3). There are few studies on the significance of these markers in non-cardiac ischemia (4). Myoglobin is a cytoplasmic heme-containing protein which is produced in cardiomyocytes and skeletal myocytes. It functions as an intracellular oxygen reservoir in muscle cells and expedites the supply of oxygen during ischemia and expedites the supply of oxygen during ischemia or exercise (5). Troponins are heteromeric proteins that play a significant role in the regulation of skeletal and cardiac muscle contraction. This family includes troponins I, T and C. Troponins are released into the circulation and may be detected in the peripheral blood 3-6 hr after an ischemic event (6). Previous studies suggested that troponin T can play an important role in risk stratification of non cardiac events via various mechanisms (6).

The aim of this study was to investigate the levels and the clinical significance of troponin T and myoglobin levels in rats with non-cardiac ischemia. Troponin T and myoglobin were chosen for this study to clarify suggestions that have been mentioned in recent studies.

Materials and Methods
Study design

This animal study was designed as a rando- mized, interventional animal study. The local animal ethics committee approved the protocol. Healthy male Wistar albino rats with an average weight of 250-300 g were procured from the Laboratory Animal Production Unit of Dicle University.

Animal subjects

Forty-eight rats were used in the experiments. The experiments were performed in laboratories with standardized conditions at 22±2°C and 50±5% humidity. A standard diet and tap water were provided ad libitum. Twelve hours prior to the expe-rimental procedure, the rats were given only water.

Study protocol

Rats were divided into six randomized equal groups. Ketamine 130 mg/kg (Ketalar, Pfizer) and xylasine 20 mg/kg (Rompun, Bayer) were used to induce anesthesia. Additionally, ketamine HCl (50 mg/kg) was used during the surgeries for anesthesia maintenance. All vital signs (respiratory rate, pulse, oxygen saturation (So2), and body temperature) were monitored.

The control group (Group I) was employed to determine the basal troponin and myoglobin levels in rats. From group I, blood samples were taken but no surgeries were performed. A sham group (Group II) was used to determine the impact of surgical incision on biochemical parameters and blood samples were taken following a simple laparotomy. Two mesenteric ischemia groups were created (group III-IV) by ligating the superior mesenteric artery (SMA) via a simple laparatomy. Intracardiac blood samples were taken 3 hr after SMA ligation in group III and 6 hr after ligation in group IV. In order to create peripheral ischemia, the left femoral artery was clamped in two groups of rats (group V-VI). Intracardiac blood samples were prepared after 3 hr of ischemia in group IV and after 6 hr in Group VI. After the experimental procedures, all rats were sacrificed.

Laboratory analysis

Point-of-care testing (POCT) by Roche (Roche Diagnostics, Mannheim, Germany) was performed on each whole blood sample. The samples were obtained in vacuum tubes (which contained separating gel and lithium heparin) and troponin T and myoglobin levels were quantified simulta-neously using a fluorescence immunoassay.

Troponin-T and myoglobin measurement

Myoglobin and troponin T levels were measured in whole blood by POCT using the Roche Cobas® h 232 immunoassay analyzer (Roche Diagnostics, Mannheim, Germany). The range of detection was 0.1 to 3 μg/l for troponin T and 30 to 700 μg/l for myoglobin (7, 8).

Statistical analysis

The results were expressed as mean±standard deviation (SD). The Kolmogorov-Smirnov test was used to determine if the data were normally distributed. Analysis of variance (ANOVA) and Bonferroni post-hoc tests were used to compare the groups. All statistical procedures were performed using SPSS software version 15.0 (SPSS Inc., Chicago, IL). A P-value of ≤0.05 was considered statistically significant.


The mean troponin T levels in groups I, II, III, IV, V, and VI were found to be 0.18±0.026, 0.21±0.034, 1.18±0.046, 0.99±0.054, 0.42±0.037, and 0.69±0.043, respectively (Figure 1). The troponin T levels were significantly higher in the study groups compared to the control group (P<0.05). Moreover, 3 hr after SMA ligation, the mean troponin T level was higher than any other study groups (Group III). A comparison of the mean troponin T values using ANOVA and post-hoc Bonferroni tests is presented in Figure 1.

The mean levels of myoglobin in groups I, II, III, IV, V, and VI were found to be 92±6.35, 104±4.34, 184±6.22, 211±8.57, 139±6.72 and 171±7.61, res-pectively (Figure 2). The myoglobin levels were significantly higher in study groups compared to the control group (P<0.05). Furthermore, higher levels were observed in the mesenteric ischemia groups at the 3rd and 6th hours (Group III-IV). Figure 2 shows the myoglobin values for groups following the statistical analysis using ANOVA and post-hoc Bonferroni tests.

As shown in Figures 1 and 2, troponin T and myoglobin have similar levels in both peripheral and mesenteric ischemia in the first six hours after the onset of ischemia. Nevertheless, the highest mean troponin T level was observed 3 hours after the onset of mesenteric ischemia. Six hours after the onset of mesenteric ischemia, the mean troponin T level (Group IV) was lower than its level at 3 hours (Group III).


Myoglobin is an essential striated muscle O2 storage protein that was demonstrated to be highly reactive with peroxidate in the presence of H2O2 mediated oxidation (9). It is responsible for the release of O2 during periods of hypoxia and anoxia. Therefore, myoglobin was investigated as a marker of ischemic muscle (9, 10). A study by van Weel et al suggested that myoglobin may lead to improved vascularization in patients with arterial obstructive disease who were treated with therapies designed to increase angiogenesis (5). These results suggest that myoglobin is an important protein in the setting of muscle tissue hypoxia and reorganization. Troponin is a contractile regulatory muscle protein complex that binds to calcium in the actin-myosin bundles within muscle fibers. There are three types of troponin, classified as troponin C, T, and I. The C type is associated with striated muscles. However, troponin I and T are closely associated with cardiac muscles (11). Although troponin I and T are specific for cardiac muscle, significant changes in both of these troponin subtypes have been reported during ischemia of other organs (12). Our findings support the idea that myoglobin and troponin T levels are increased in both mesenteric and peripheral ischemia.

Troponin T levels were investigated in patients undergoing surgery for an abdominal aortic aneurysm or lower extremity arterial obstruction (13). The authors suggested that elevated troponin T levels may predict late mortality. In another study, it was found that troponin T was increased in patients with acute limb ischemia. Additionally, in that study it was suggested that troponin T levels may be an early marker of overall disease severity and a predictor of outcome (14). Also, it was reported that elevated troponin I is a common finding in patients with acute mesenteric ischemia (3). Myoglobin has also been investigated as a biomarker in ischemic tissues, especially in ischemic muscles (9, 10). Although the specific role of myoglobin in hypoxia is unclear, previous reports have suggested that hypoxia regulates myoglobin expression and myoglobin prodution is an adaptive response to hypoxic conditions (15, 16). Yang et al studied myoglobin expression in an experimental hindlimb ischemia model in mice. They concluded that elevated myoglobin expression in ischemic skeletal muscle reduces the endogenous perfusion recovery (16). The role of vascular myoglobin in hypoxic conditions was studied and it was suggested that myoglobin contributes to nitrite-induced vasodi-lation in these conditions, significantly (17). In this study, we created experimental acute mesenteric and peripheral ischemia by clamping sustaining arteries and then drew blood samples three and six hr after the ischemic event. Troponin T and myoglobin values were measured in these blood samples. We found that these two markers were significantly elevated (P<0.05) in both peripheral and mesenteric ischemia. The highest troponin T levels were observed in the samples taken three hr after the onset of mesenteric ischemia and the highest myoglobin levels were seen in samples taken six hr after mesenteric ischemia. Other findings were similar in both peripheral and mesenteric ischemia experimental groups.


We could mention that troponin T and myoglobin are not specific markers for mesenteric or peripheral ischemia. Therefore, there is no diagnostic value when they are in normal ranges. However, in patients with positive troponin or myoglobin without an underlying cardiac cause, it is likely that ischemia is present in another tissue.


Declaration of interest

The authors declare no conflicts of interest with respect to the authorship and/or publication of this article.


The authors received no financial support for the research and/or authorship of this article.

1. Block T. Acute occlusion of the superior mesenteric arteryDiagnosis and treatment. [dissertation]Year: 2010UppsalaUppsala universities
2. Kehl DW,Iqbal N,Fard A,Kipper BA,De La Parra Landa A,Maisel AS. Biomarkers in acute myocardial injuryTransl ResYear: 201215925226422424429
3. Acosta S,Block T,Björnsson S,Resch T,Björck M,Nilsson T. Diagnostic pitfalls at admission in patients with acute superior mesenteric artery occlusionJ Emerg MedYear: 20124263564122137151
4. Koutouzis M,Kontaras K,Sfyroeras G,Moulakakis K,Nikolidakis S,Andrikopoulos V,et al. Cardiac troponin I in patients with acute lower limb ischemiaAm J CardiolYear: 200710072873017697837
5. Van Weel V,Deckers MM,Grimbergen JM,Van Leuven KJ,Lardenoye JH,Schlingemann RO,et al. Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivoCirc ResYear: 200495586615155530
6. Dawson-Bowling S,Chettiar K,Cottam H,Worth R,Forder J,Fitzgerald-O’ Connor I,et al. Troponin T asa predictive marker of morbidity in patients with fractured neck of femurInjuryYear: 20083977578018407276
7. Apple FS,Quist HE,Doyle PJ,Otto AP,Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendationsClin ChemYear: 2003491331133612881449
8. Müller-Bardorff M,Sylvén C,Rasmanis G,Jørgensen B,Collinson PO,Waldenhofer U,et al. Evaluation of a point-of-care system for quantitative determination of toponin T and myoglobinClin Chem Lab MedYear: 20003856757410987207
9. Kamin-Belsky N,Tomashov R,Arav R,Shaklai N. Involvement of the oxygen storage protein myoglobin in muscle damage under oxidative stressAdv Exp Med BiolYear: 19984542192239889895
10. Ordway GA,Garry DJ. Myoglobin: an essential hemoprotein in striated muscleJ Exp BiolYear: 20042073441333615339940
11. Babuin L,Jaffe AS. Troponin:the biomarker of choice for the detection of cardiac injuryCMAJYear: 20051731191120216275971
12. Hasırcı B,Okay M,Ağırcan D,Koçer A. Elevated troponin level with negative outcome was found in ischemic strokeCardiovasc Psychiatry Neurol 2013Year: 2013 953672.
13. Feringa HH,Bax JJ,de Jonge R,Elhendy A,van Domburg RT,Dunkelgrun M,et al. Impact of glomerular filtration rate on minor troponin T elevations for risk assessment in patients undergoing operation for abdominal aortic aneurysm or lower extremity arterial obstructionAm J CardiolYear: 2006981515151817126662
14. Rittoo D,Stahnke M,Lindesay C,Grocott E,Hickey N,Downing R. Prognostic significance of raised cardiac troponin T in patients presenting with acute limb ischaemiaEur J Vasc Endovasc SurgYear: 20063250050316716613
15. Kanatous SB,Mammen PP,Rosenberg PB,Martin CM,White MD,Dimaio JM,et al. Hypoxia reprograms calcium signaling and regulates Myoglobin expressionAm J Physiol Cell PhysiolYear: 2009296393402
16. Yang YG,Guan H,Liu CW,Li YJ. Myoglobin over-expression attenuates angiogenic response in hindlimb ischemia in miceChin Med J (Engl)Year: 20091221056106019493440
17. Ormerod JO,Ashrafian H,Maher AR,Arif S,Steeples V,Born GV,et al. The role of vascular myoglobin in nitrite-mediated blood vessel relaxationCardiovasc ResYear: 20118956056520889759


[Figure ID: F1]
Figure 1 

Comparison of troponin t levels among all groups

Group I: Control group, group II: Sham group, group III: Three hr after mesenteric ischemia, group IV: Six hr after mesenteric ischemia, group V: Three hr after peripheral ischemia and group VI: Six hr after peripheral ischemia. P<0.05 is considered significant

[Figure ID: F2]
Figure 2 

Comparison of myoglobin levels among all groups

Group I: Control group, group II: Sham group, group III: Three hr after mesenteric ischemia, group IV: Six hr after mesenteric ischemia, group V: Three hr after peripheral ischemia and group VI: six hr after peripheral ischemia. P<0.05 is considered significant

Article Categories:
  • Original Article

Keywords: Mesenteric ischemia, Myoglobin, Peripheral ischemia, Troponin T.

Previous Document:  Allopregnanolone suppresses diabetes-induced neuropathic pain and motor deficit through inhibition o...
Next Document:  Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP...